Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Whitehawk Therapeutics (WHWK) Return on Assets: 2019-2025

Historic Return on Assets for Whitehawk Therapeutics (WHWK) over the last 6 years, with Sep 2025 value amounting to -0.59%.

  • Whitehawk Therapeutics' Return on Assets rose 7.00% to -0.59% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.59%, marking a year-over-year increase of 7.00%. This contributed to the annual value of -0.63% for FY2024, which is 21.00% down from last year.
  • Latest data reveals that Whitehawk Therapeutics reported Return on Assets of -0.59% as of Q3 2025, which was down 25.52% from -0.47% recorded in Q2 2025.
  • In the past 5 years, Whitehawk Therapeutics' Return on Assets ranged from a high of -0.05% in Q2 2021 and a low of -1.00% during Q2 2022.
  • Moreover, its 3-year median value for Return on Assets was -0.47% (2025), whereas its average is -0.52%.
  • In the last 5 years, Whitehawk Therapeutics' Return on Assets crashed by 95bps in 2022 and then skyrocketed by 63bps in 2023.
  • Whitehawk Therapeutics' Return on Assets (Quarterly) stood at -0.67% in 2021, then spiked by 35bps to -0.32% in 2022, then declined by 14bps to -0.46% in 2023, then tumbled by 35bps to -0.82% in 2024, then climbed by 7bps to -0.59% in 2025.
  • Its Return on Assets was -0.59% in Q3 2025, compared to -0.47% in Q2 2025 and -0.39% in Q1 2025.